Detalhe da pesquisa
1.
Biodegradable polymer sirolimus-eluting stents versus durable polymer everolimus-eluting stents in patients with ST-segment elevation myocardial infarction (BIOSTEMI): a single-blind, prospective, randomised superiority trial.
Lancet
; 394(10205): 1243-1253, 2019 10 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-31488372
2.
Ultrathin-strut, biodegradable-polymer, sirolimus-eluting stents versus thin-strut, durable-polymer, everolimus-eluting stents for percutaneous coronary revascularisation: 5-year outcomes of the BIOSCIENCE randomised trial.
Lancet
; 392(10149): 737-746, 2018 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30170848
3.
Design and rationale of the Management of High Bleeding Risk Patients Post Bioresorbable Polymer Coated Stent Implantation With an Abbreviated Versus Standard DAPT Regimen (MASTER DAPT) Study.
Am Heart J
; 209: 97-105, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30703644
4.
Biodegradable-polymer stents versus durable-polymer stents - Authors' reply.
Lancet
; 393(10184): 1933, 2019 05 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31084961
5.
Ultrathin strut biodegradable polymer sirolimus-eluting stent versus durable polymer everolimus-eluting stent for percutaneous coronary revascularisation (BIOSCIENCE): a randomised, single-blind, non-inferiority trial.
Lancet
; 384(9960): 2111-22, 2014 Dec 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-25189359
6.
Long-term clinical outcomes of biodegradable polymer biolimus-eluting stents versus durable polymer sirolimus-eluting stents in patients with coronary artery disease (LEADERS): 4 year follow-up of a randomised non-inferiority trial.
Lancet
; 378(9807): 1940-8, 2011 Dec 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-22075451
7.
Effect of biolimus-eluting stents with biodegradable polymer vs bare-metal stents on cardiovascular events among patients with acute myocardial infarction: the COMFORTABLE AMI randomized trial.
JAMA
; 308(8): 777-87, 2012 Aug 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-22910755
8.
Five-Year Outcomes With Biodegradable-Polymer Sirolimus-Eluting Stents Versus Durable-Polymer Everolimus-Eluting Stents in Patients With Acute Coronary Syndrome: A Subgroup Analysis of the BIOSCIENCE Trial.
Cardiovasc Revasc Med
; 34: 3-10, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33653633
9.
Long-term tissue coverage of a biodegradable polylactide polymer-coated biolimus-eluting stent: comparative sequential assessment with optical coherence tomography until complete resorption of the polymer.
Am Heart J
; 162(5): 922-31, 2011 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-22093210
10.
An optical coherence tomography study of a biodegradable vs. durable polymer-coated limus-eluting stent: a LEADERS trial sub-study.
Eur Heart J
; 31(2): 165-76, 2010 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-19889649
11.
Biodegradable- Versus Durable-Polymer Drug-Eluting Stents for STEMI: Final 2-Year Outcomes of the BIOSTEMI Trial.
JACC Cardiovasc Interv
; 14(6): 639-648, 2021 03 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-33727005
12.
Biolimus-eluting stent with biodegradable polymer versus sirolimus-eluting stent with durable polymer for coronary revascularisation (LEADERS): a randomised non-inferiority trial.
Lancet
; 372(9644): 1163-73, 2008 Sep 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-18765162
13.
Five-Year Outcomes in Patients With Diabetes Mellitus Treated With Biodegradable Polymer Sirolimus-Eluting Stents Versus Durable Polymer Everolimus-Eluting Stents.
J Am Heart Assoc
; 8(22): e013607, 2019 11 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-31696762
14.
Report of an ESC-EAPCI Task Force on the evaluation and use of bioresorbable scaffolds for percutaneous coronary intervention: executive summary.
EuroIntervention
; 13(13): 1574-1586, 2018 01 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-28948934
15.
Midterm clinical outcomes with everolimus-eluting bioresorbable scaffolds versus everolimus-eluting metallic stents for percutaneous coronary interventions: a meta-analysis of randomised trials.
EuroIntervention
; 13(13): 1565-1573, 2018 01 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-28671552
16.
A comparison of an ultrathin-strut biodegradable polymer sirolimus-eluting stent with a durable polymer everolimus-eluting stent for patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: rationale and design of the BIOSTEMI trial.
EuroIntervention
; 14(6): 692-699, 2018 Aug 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-29205157
17.
Impact of Patient and Lesion Complexity on Long-Term Outcomes Following Coronary Revascularization With New-Generation Drug-Eluting Stents.
Am J Cardiol
; 119(4): 501-507, 2017 02 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-27923461
18.
Ultrathin Strut Biodegradable Polymer Sirolimus-Eluting Stent Versus Durable-Polymer Everolimus-Eluting Stent for Percutaneous Coronary Revascularization: 2-Year Results of the BIOSCIENCE Trial.
J Am Heart Assoc
; 5(3): e003255, 2016 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-26979080
19.
Five-year outcomes of chronic total occlusion treatment with a biolimus A9-eluting biodegradable polymer stent versus a sirolimus-eluting permanent polymer stent in the LEADERS all-comers trial.
Cardiol J
; 23(6): 626-636, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27665852
20.
Long-term outcomes of biodegradable versus durable polymer drug-eluting stents in patients with acute ST-segment elevation myocardial infarction: a pooled analysis of individual patient data from three randomised trials.
EuroIntervention
; 10(12): 1425-31, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-24602961